Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source…
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.…
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional…
Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss…
MarketsHeard on the StreetStrong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose…